Montag & Associates’s Cognizant CTSH Stock Holding History

Montag & Associates’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-38	Closed	-$2.55K	–	1011
2025 Q3	$2.55K	Buy	+38	New	+$2.75K	﹤0.01%	892

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Montag & Associates's CTSH Position: Q4 2025 in Review

Montag & Associates sold out of Cognizant (CTSH) in Q4 2025, closing a stake of 38 shares — an estimated $2.55K sold.

Montag & Associates first reported a position in CTSH in Q3 2025 and held it in 1 quarter. The position peaked at $2.55K in Q3 2025. 1,057 funds tracked by Wall St. Rank hold CTSH as of Q4 2025.

Montag & Associates reported no remaining Cognizant position as of Q4 2025 after selling out during the quarter.
Montag & Associates sold 38 Cognizant shares in Q4 2025, an estimated $2.55K.
Montag & Associates first reported a position in Cognizant in Q3 2025 and held it in 1 quarter.
Montag & Associates's Cognizant position peaked at $2.55K in Q3 2025.
1,057 funds tracked by Wall St. Rank held Cognizant as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.